BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//app.ishl.eu//Schedule
X-WR-CALNAME:ISHL14
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/Berlin
TZURL:http://tzurl.org/zoneinfo-outlook/Europe/Berlin
X-LIC-LOCATION:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19700329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19701025T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-268@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T083000
DTEND;TZID=Europe/Berlin:20261003T110000
SUMMARY:Workshop 1 - Workshop on ctDNA in HL
LOCATION:Marsilius Saal (Gürzenich)
DESCRIPTION:Talks: Part I: ctDNA for MRD, intermission, Part II: ctDNA for Genotyping and Classifying HL
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/268" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Workshop 1 - Workshop on ctDNA in HL
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-269@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T083000
DTEND;TZID=Europe/Berlin:20261003T110000
SUMMARY:Scientific Session 1 - EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Large B-cell lymphomas, Mantle cell lymphoma, Follicular lymphoma, HIV-related lymphomas, Peripheral T-cell lymphoma, New Therapeutic Concepts and Horizons in Lymphoma
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/269" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 1 - EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-287@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T083000
DTEND;TZID=Europe/Berlin:20261003T110000
SUMMARY:Workshop 2 - Individualization of Radiation Therapy for Hodgkin Lymphoma
LOCATION:Ratsstube (Gürzenich)
DESCRIPTION:Talks: Early-Stages and Indvidualization, Advanced Stages/Recurrence, Older age, NLPHL, Round Table Discussion:  How low can we go with dose and fields?
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/287" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Workshop 2 - Individualization of Radiation Therapy for Hodgkin Lymphoma
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-270@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T113000
DTEND;TZID=Europe/Berlin:20261003T130000
SUMMARY:Satellite Symposium - Moving Targets: Rethinking Cellular Therapy Delivery in Aggressive B-Cell Lymphomas
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Opening and Framing, R/R DLBCL Treatment Landscape, Difficult-to-Treat Patients in R/R DLBCL, CAR-T Delivery and Treatment Timing: Clinical Challenges and Opportunities, Future Directions in Cellular Therapy, Panel Discussion and Q&A
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/270" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Satellite Symposium - Moving Targets: Rethinking Cellular Therapy Delivery in Aggressive B-Cell Lymphomas
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-271@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T131500
DTEND;TZID=Europe/Berlin:20261003T144500
SUMMARY:Scientific Session 2 - Early Stages
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Personalized RTx: Focus on RTx Techniques and Late Effect Prediction Models, Just PD1-Inhibition? Early Insights from the GHSG INDIE Trial, Debate: Should Novel Agents Be Integrated Into the Frontline Treatment of Early Stage Low Risk HL Patients?, Abstract T082: Radiation-free initial treatment of early-stage favorable classic Hodgkin Lymphoma (RAFTING) trial: three-year follow-up, Abstract T083: Integrating E-HIPI and Interim PET to Refine Risk Stratification in Early-Stage Classic Hodgkin Lymphoma
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/271" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 2 - Early Stages
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-272@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T150000
DTEND;TZID=Europe/Berlin:20261003T163000
SUMMARY:Satellite Symposium - Raising the bar in cHL: From frontline treatment to long-term impact
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Welcome and introduction, The current treatment landscape and challenges in cHL, Current and emerging frontline treatment strategies in adult and elderly patients with cHL, N-AVD vs BrECADD in advanced stage frontline cHL, Current and emerging frontline and R/R treatment strategies in pediatric patients with cHL, Panel Q&A session and discussion, Summary and close
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/272" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Satellite Symposium - Raising the bar in cHL: From frontline treatment to long-term impact
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-273@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T170000
DTEND;TZID=Europe/Berlin:20261003T183000
SUMMARY:Main Program - Opening Ceremony with Keynote Lecture & Awards
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Welcome Address, A Generation of Research on Hodgkin Lymphoma, Karl-Musshoff Awards & Poster Awards, Keynote Lecture: Changing treatment paradigms in B cell Lymphoma
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/273" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Main Program - Opening Ceremony with Keynote Lecture & Awards
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-274@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261003T183000
DTEND;TZID=Europe/Berlin:20261003T200000
SUMMARY:Main Program - Poster Session &  Welcome Reception
LOCATION:Foyer (Ground Floor) (Gürzenich)
DESCRIPTION:Talks: Project Pitch & Collaboration Plaza, Early Stages, HL in Children & Adolescents, Biology & Pathology, Living Beyond Lymphoma, Advanced Stages, Resource Constrained Settings, NLPHL, Relapsed & Refractory HL
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-03/session/274" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Main Program - Poster Session &  Welcome Reception
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-275@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T080000
DTEND;TZID=Europe/Berlin:20261004T091500
SUMMARY:Scientific Session 3 - HL in Children and Adolescents
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Treatment Evolution in Pediatric Hodgkin Lymphoma: From Research to Real-World Impact, Precision Medicine in Pediatric HL / Harmonized Pediatric HL Protocol in South Africa, Abstract T071: The Genomic Landscape of Pediatric High-Risk Hodgkin Lymphoma: A Liquid Biopsy Study of COG AHOD1331, Abstract T072: Body-Size Normalisation of Metabolic Tumour Volume in Paediatric Hodgkin Lymphoma: Does MTV/BSA Improve Prognostic Stratification and Reclassify Smaller Children?
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/275" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 3 - HL in Children and Adolescents
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-288@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T080000
DTEND;TZID=Europe/Berlin:20261004T100000
SUMMARY:Workshop 3 - Closed Workshop on Grassroot Initiative in Classic Hodgkin Lymphoma
LOCATION:Ratsstube (Gürzenich)
DESCRIPTION:
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/288" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Workshop 3 - Closed Workshop on Grassroot Initiative in Classic Hodgkin Lymphoma
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-276@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T093000
DTEND;TZID=Europe/Berlin:20261004T103000
SUMMARY:Satellite Symposium - New concepts for the treatment of B-cell lymphomas
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: DLBCL – The current and future role of ADCs in the context of T-cell engaging therapies, cHL – Treatment strategies for PD-1 inhibition in the relapsed / refractory setting
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/276" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Satellite Symposium - New concepts for the treatment of B-cell lymphomas
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-277@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T104500
DTEND;TZID=Europe/Berlin:20261004T120000
SUMMARY:Scientific Session 4 - Translating ctDNA into clinical routine
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Circulating Tumor DNA: New insights from the SWOG S1826 study., Circulating Tumor DNA Analysis for Classification and MRD Assessment – Experience of the German Hodgkin Study Group, Workshop Report, Abstract T048: A Reproducible Mutation- versus Copy-Number-Enriched Genomic Axis Underlies Molecular Subtypes of Classic Hodgkin Lymphoma
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/277" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 4 - Translating ctDNA into clinical routine
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-278@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T121500
DTEND;TZID=Europe/Berlin:20261004T133000
SUMMARY:Scientific Session 5 - Biology & Pathology
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: The Biology of HRS Cells, Novel Insights Into the Microenvironment of Hodgkin Lymphoma, Abstract T046: Functional characterization of STAT6 mutations as oncogenic drivers in classical Hodgkin lymphoma (cHL), Abstract T047: Artificial intelligence predicts EBV status and reveals prognostic morphology phenotypes in advanced-stage classic Hodgkin lymphoma
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/278" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 5 - Biology & Pathology
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-279@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T134500
DTEND;TZID=Europe/Berlin:20261004T151500
SUMMARY:Satellite Symposium - From Evidence to Experience: How Long-Term and Real-World Data for ADCETRIS® (brentuximab vedotin) May Inform Frontline Practice in Advanced Hodgkin Lymphoma
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Welcome and Introductions, Enhancing Frontline Management in Advanced HL with BrECADD, Advancing HL Control and Fertility Preservation with BrECADD, Optimizing Care in High-Risk HL with A+AVD, Engage with the Experts (Q&A), Meeting close 
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/279" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Satellite Symposium - From Evidence to Experience: How Long-Term and Real-World Data for ADCETRIS® (brentuximab vedotin) May Inform Frontline Practice in Advanced Hodgkin Lymphoma
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-280@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T153000
DTEND;TZID=Europe/Berlin:20261004T170000
SUMMARY:Scientific Session 6 - Living Beyond Lymphoma
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Evaluating Late Effects of Contemporary Treatments - Competing Risks & Novel Approaches, Uncertainties with Anti-PD1 & irAE in the First-Line Setting, In Conversation with GHSG Patient Representatives: Building a Bridge Between Cancer Treatment and Everyday Life – Challenges After Lymphoma, Abstract T092: Patients with a history of Hodgkin lymphoma have lower quality of life than matched comparators regardless of time elapsed since diagnosis, Abstract T093: The MyHodgkin MyHealth App: patient-derived data for tracking Hodgkin Lymphoma survivorship
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/280" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 6 - Living Beyond Lymphoma
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-281@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261004T170000
DTEND;TZID=Europe/Berlin:20261004T183000
SUMMARY:Scientific Session 7 - Advanced Stages
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Unmet Needs and Future Perspectives with BrECADD: Improving Outcomes of HD21 , Unmet Needs and Future Perspectives with Nivo-AVD: Unanswered Questions from SWOG S1826, Abstract T001: CHOP/miniCHOP And Tislelizumab in EldeRly patients with classical Hodgkin Lymphoma (cHL). A report of the phase II CATER-HL trial (HD12) from the Australasian Lymphoma and Leukaemia Group (ALLG), Abstract T002: Simplified Geriatric Assessment (sGA) in Older Patients With Classical Hodgkin Lymphoma (cHL): The Prospective ELDHL Project of the Fondazione Italiana Linfomi (FIL), Abstract T003: Durable Remissions and Late Immune-Related Toxicities After Frontline Pembrolizumab + AVD in Classic Hodgkin Lymphoma
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-04/session/281" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 7 - Advanced Stages
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-282@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261005T080000
DTEND;TZID=Europe/Berlin:20261005T091500
SUMMARY:Scientific Session 8 - Special Cases & Situations
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: HL in Pregnancy, Critical Organ Failure at Presentation, Anti-PD1 Tx in Pre-Existing Autoimmune Disease, Workshop Report “Grassroot Initiative in Classic Hodgkin Lymphoma”
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-05/session/282" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 8 - Special Cases & Situations
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-283@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261005T093000
DTEND;TZID=Europe/Berlin:20261005T103000
SUMMARY:Scientific Session 9 - NLPHL
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Clinical Implications of Growth Patterns, Treatment Strategies, Abstract T101: Single-Nuclei and Spatial Transcriptomic Analysis of Nodular Lymphocyte- Predominant Hodgkin Lymphoma (NLPHL), Abstract T102: Malignant LP cells build a stroma-poor, avascular niche that concentrates IDO1+ macrophages and excludes regulatory T cells in NLPHL and THRLBCL
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-05/session/283" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 9 - NLPHL
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-284@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261005T104500
DTEND;TZID=Europe/Berlin:20261005T121500
SUMMARY:Scientific Session 10 - Relapsed & Refractory HL
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: 2L Treatment of HL in Era of Novel Agents, Revisiting the Role of Stem Cell Transplantation in rrHL, Unmet Needs and Novel Treatment Approaches in >3L, Abstract T106: Phase 1 PRIMAVERA Study of the PRMT5 Inhibitor AZD3470 in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma, Abstract T107: Treatment patterns and survival outcomes of patients relapsing after frontline Nivolumab-AVD in advanced stage classical Hodgkin lymphoma (cHL), Abstract T108: Primary Analysis of the GHSG Pembro-CORE Trial: PET-Adapted PD-1-Based Salvage Therapy Omitting High-Dose Chemotherapy in First-Relapsed Hodgkin Lymphoma
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-05/session/284" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Scientific Session 10 - Relapsed & Refractory HL
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20261013T152500
UID:session-285@app.ishl.eu/2026
DTSTART;TZID=Europe/Berlin:20261005T121500
DTEND;TZID=Europe/Berlin:20261005T130000
SUMMARY:Main Program - Best of ISHL14
LOCATION:Großer Saal (Gürzenich)
DESCRIPTION:Talks: Best of ISHL14, Farewell
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><BODY><a href="https://app.ishl.eu/2026/#/program/2026-10-05/session/285" target="_blank">View Online</a></BODY></HTML>
BEGIN:VALARM
DESCRIPTION:Main Program - Best of ISHL14
ACTION:DISPLAY
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR
